Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy

Hospices Civils de Lyon · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
immunotherapylungcancermelanomamonitoringnanivolumab
melanoma, lung cancer, renal cancer, tele-monitoring, nivolumab, ipilimumab, immunotherapy, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 841103
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.